Production of Mass-Separated Erbium-169 Towards the First Preclinical in vitro Investigations

Overview of attention for article published in Frontiers in Medicine, April 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 17 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 10,322 followers.

RT @ILLGrenoble: Check out also this recent #OpenAccess @FrontMedicine article concerning the production and purification of #Erbium169 for…

29 Apr 2021

Reply Repost Favourite

RT @ILLGrenoble: Check out also this recent #OpenAccess @FrontMedicine article concerning the production and purification of #Erbium169 for…

29 Apr 2021

Reply Repost Favourite

Check out also this recent #OpenAccess @FrontMedicine article concerning the production and purification of #Erbium169 for #cancer treatment @ILLGrenoble with the help of @psich_en and @CERN #MEDICIS facilities. ➡️ https://t.co/fY3Evjff4n #radionuclide #Nu

28 Apr 2021

Reply Repost Favourite

New Research: Production of Mass-Separated Erbium-169 Towards the First Preclinical in vitro Investigations: The β−-particle-emitting erbium-169 is a potential radionuclide toward therapy of metastasized cancer… https://t.co/hK7j1diATC #medicalcare #clinic

26 Apr 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.